KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $2.9 billion.

  • Chemed's Retained Earnings rose 940.17% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 940.17%. This contributed to the annual value of $2.7 billion for FY2024, which is 1123.48% up from last year.
  • Chemed's Retained Earnings amounted to $2.9 billion in Q3 2025, which was up 940.17% from $2.8 billion recorded in Q2 2025.
  • Chemed's 5-year Retained Earnings high stood at $2.9 billion for Q3 2025, and its period low was $1.8 billion during Q1 2021.
  • Moreover, its 5-year median value for Retained Earnings was $2.3 billion (2023), whereas its average is $2.3 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first soared by 2083.72% in 2021, then soared by 940.17% in 2025.
  • Chemed's Retained Earnings (Quarter) stood at $2.0 billion in 2021, then grew by 11.55% to $2.2 billion in 2022, then grew by 11.33% to $2.4 billion in 2023, then grew by 11.23% to $2.7 billion in 2024, then rose by 6.07% to $2.9 billion in 2025.
  • Its Retained Earnings was $2.9 billion in Q3 2025, compared to $2.8 billion in Q2 2025 and $2.8 billion in Q1 2025.